Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Algae Health Sciences is a private U.S.-based subsidiary of BGG focused on researching, producing, and marketing algae-derived nutraceutical ingredients. The company’s flagship commercial product is AstaZine, a natural astaxanthin ingredient produced from Haematococcus pluvialis microalgae, and it also markets FucoMAX fucoidan and ThinOgen fucoxanthin. Its products are positioned for use in dietary supplements, cosmetics, and food and beverage applications rather than as prescription therapeutics. Algae Health Sciences emphasizes large-scale controlled microalgae cultivation, clinically supported ingredient claims, and premium natural ingredient manufacturing. The business is best understood as a commercial health-ingredient and nutraceutical platform company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Algae Health Sciences.